Management of Pleural Effusion Secondary to Malignant Mesothelioma

被引：1
作者：
Musso, Valeria [1 ,2 ]
Diotti, Cristina [1 ,2 ]
Palleschi, Alessandro [1 ,2 ]
Tosi, Davide [1 ]
Aiolfi, Alberto [3 ,4 ]
Mendogni, Paolo [1 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Thorac Surg & Lung Transplantat Unit, I-20122 Milan, Italy
[2] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
[3] Univ Milan, Dept Biomed Sci Hlth, I-20133 Milan, Italy
[4] Ist Clin St Ambrogio, Div Gen Surg, I-20149 Milan, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 18期
关键词：
malignant pleural effusion; malignant pleural mesothelioma; mesothelioma; indwelling pleural catheter; talc poudrage; TALC PLEURODESIS; EFFICACY; DIAGNOSIS; CATHETER;
D O I：
10.3390/jcm10184247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Malignant pleural mesothelioma (MPM) is a highly aggressive pleural tumour which has been epidemiologically linked to occupational exposure to asbestos. MPM is often associated with pleural effusion, which is a common cause of morbidity and whose management remains a clinical challenge. In this review, we analysed the literature regarding the diagnosis and therapeutic options of pleural effusion secondary to mesothelioma. Our aim was to provide a comprehensive view on this subject, and a new algorithm was proposed as a practical aid to clinicians dealing with patients suffering from pleural effusion.
引用
收藏
页数：9
相关论文
共 32 条
  • [1] Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients[J]. Affatato, Roberta;Mendogni, Paolo;Del Gobbo, Alessandro;Ferrero, Stefano;Ricci, Francesca;Broggini, Massimo;Rosso, Lorenzo. CANCERS, 2020(12)
  • [2] Biomarkers in mesothelioma[J]. Arnold, David T.;Maskell, Nick A. ANNALS OF CLINICAL BIOCHEMISTRY, 2018(01)
  • [3] To Seed or Not to Seed The Open Question of Mesothelioma Intervention Tract Metastases[J]. Bertolaccini, Luca;Viti, Andrea;Terzi, Alberto. CHEST, 2014(03)
  • [4] Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion[J]. Bhatnagar, R.;Keenan, E. K.;Keenan, E. K.;Morley, A. J.;Kahan, B. C.;Stanton, A. E.;Haris, M.;Harrison, R. N.;Mustafa, R. A.;Bishop, L. J.;Ahmed, L.;West, A.;Holme, J.;Evison, M.;Munavvar, M.;Sivasothy, P.;Herre, J.;Cooper, D.;Roberts, M.;Guhan, A.;Hooper, C.;Walters, J.;Saba, T. S.;Chakrabarti, B.;Gunatilake, S.;Psallidas, I.;Walker, S. P.;Bibby, A. C.;Smith, S.;Stadon, L. J.;Zahan-Evans, N. J.;Lee, Y. C. G.;Harvey, J. E.;Rahman, N. M.;Miller, R. F.;Maskell, N. A. NEW ENGLAND JOURNAL OF MEDICINE, 2018(14)
  • [5] Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT[J]. Bhatnagar, Rahul;Luengo-Fernandez, Ramon;Kahan, Brennan C.;Rahman, Najib M.;Miller, Robert F.;Maskell, Nick A. HEALTH TECHNOLOGY ASSESSMENT, 2020(26)
  • [6] The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma A Prospective, Single-Center Cohort Study of 229 Patients[J]. Bibby, Anna C.;Halford, Paul;De Fonseka, Duneesha;Morley, Anna J.;Smith, Sarah;Maskell, Nick A. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019(10)
  • [7] ERS/EACTS statement on the management of malignant pleural effusions[J]. Bibby, Anna C.;Dorn, Patrick;Psallidas, Ioannis;Porcel, Jose M.;Janssen, Julius;Froudarakis, Marios;Subotic, Dragan;Astoul, Phillippe;Licht, Peter;Schmid, Ralph;Scherpereel, Arnaud;Rahman, Najib M.;Cardillo, Giuseppe;Maskell, Nick A. EUROPEAN RESPIRATORY JOURNAL, 2018(01)
  • [8] Surgery in Malignant Pleural Mesothelioma[J]. Bueno, Raphael;Opitz, Isabelle. JOURNAL OF THORACIC ONCOLOGY, 2018(11)
  • [9] The Diagnostic Value of Transthoracic Ultrasonographic Features in Predicting Malignancy in Undiagnosed Pleural Effusions: A Prospective Observational Study[J]. Bugalho, Antonio;Ferreira, Dalila;Dias, Sara S.;Schuhmann, Maren;Branco, Jose C.;Marques Gomes, Maria J.;Eberhardt, Ralf. RESPIRATION, 2014(04)
  • [10] The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion[J]. Chen, D.;Li, X.;Zhao, H.;Fu, Y.;Yao, F.;Hu, J.;Du, N. INDIAN JOURNAL OF CANCER, 2014(07)
1234